CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853899721
- Phone
- 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-29 | Sessa Capital (Master), L.P. Director | Option exercise · Series B Convertible Preferred Stock | −17,400 | 211,100 | ||
| 2025-09-19 | Kropotova Alexandra CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,977 | 45,272 | ||
| 2025-08-26 | Reich Samuel J CEO & EXECUTIVE CHAIRMAN | Grant or award · Stock Option (right to buy) | +4,800,000 | 4,800,000 | ||
| 2025-08-26 | To Lucy See Remarks | Grant or award · Stock Option (right to buy) | +1,200,000 | 1,200,000 | ||
| 2025-08-26 | Kropotova Alexandra CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy) | +2,400,000 | 2,400,000 | ||
| 2025-08-26 | Bausch Christoph Lawrence CHIEF OPERATING OFFICER | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2025-08-26 | Sullivan Eddie Joe PRESIDENT | Grant or award · Stock Option (right to buy) | +3,000,000 | 3,000,000 | ||
| 2025-07-22 | Sessa Capital (Master), L.P. Director | Grant or award · Series B Convertible Preferred Stock | +228,500 | 228,500 | ||
| 2025-07-22 | Sessa Capital (Master), L.P. Director | Grant or award · Warrants (right to buy) | +228,500 | 228,500 | ||
| 2025-07-22 | Sessa Capital (Master), L.P. Director | Grant or award · Warrants (right to buy) | +114,250 | 114,250 | ||
| 2025-07-22 | Moin Andrew Director | Grant or award · Series B Convertible Preferred Stock | +228,500 | 228,500 | ||
| 2025-07-22 | Moin Andrew Director | Grant or award · Warrants (right to buy) | +228,500 | 228,500 | ||
| 2025-07-22 | Moin Andrew Director | Grant or award · Warrants (right to buy) | +114,250 | 114,250 | ||
| 2025-03-27 | Kropotova Alexandra CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,179 | 47,249 | ||
| 2024-12-18 | Kropotova Alexandra CHIEF MEDICAL OFFICER | Shares withheld for taxes | −9,072 | 48,428 | ||
| 2024-11-01 | Ellias Helen K. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-11-01 | Ellias Helen K. Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-08-12 | To Lucy See Remarks | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2024-07-15 | SKYLER JAY S Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-07-15 | SKYLER JAY S Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 |
Page 2 of 9 · 172 trades